A sample of the silver-containing sodium carboxymethyl cellulose wound dressing was aseptically transferred to a simulated wound fluid containing A. baumannii, C. difficile, community-associated MRSA or ESBL-producing bacteria. Following incubation, total viable counts were performed on each test model at four, 24, 48, 72, and 96 hours and at seven days. All models were re-inoculated with a fresh challenge of the same bacteria at 72 hours.
The dressing killed ESBL-producing bacteria and A. baumannii quickly and consistently, with an approximate 100,000-fold reduction of all pathogens within 24 hours. The rate of kill for C. difficile was rapid, with an approximate 100,000-fold reduction of all bacteria after four hours. The wound dressing also was effective against CA-MRSA, with a 100-fold reduction in bacterial population within 48 hours and no bacteria detected by day seven.
Read the news release about ionic silver wound dressing.
Read other coverage about infection control:
– Honey May Help in Fight Against Antibiotic-Resistant Bacteria
– Pronovost: Physician Attitudes Toward Infections Need Work
– 14 Hospitals Partner With Premier in ED Safety Initiative
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
